British Journal of Clinical Pharmacology

Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs
pp. 111-122(12)
Authors: Bertilsson L.; Dahl M-L.; Dalén P.; Al-Shurbaji A.

The promise of new antiepileptic drugs
pp. 123-131(9)
Author: Duncan J.S.

Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers
pp. 133-139(7)
Authors: Swart E.L.; van der Hoven B.; Johan Groeneveld A.B.; Touw D.J.; Danhof M.

Pharmacokinetics of a contraceptive patch (Evra^™/Ortho Evra^™) containing norelgestromin and ethinyloestradiol at four application sites
pp. 141-146(6)
Authors: Abrams L.S.; Skee D.M.; Natarajan J.; Wong F.A.; Anderson G.D.

Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects
pp. 147-154(8)
Authors: Gaussem P.; Dubar M.; le Bonniec B.; Richard-Lordereau I.; Jochemsen R.; Aiach M.

Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects
pp. 155-162(8)
Authors: Frye R.F.; Branch R.A.

Management of Helicobacter pylori eradication – the influence of structured counselling and follow-up
pp. 163-171(9)
Authors: Al-Eidan F.A.; McElnay J.C.; Scott M.G.; McConnell J.B.

Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark
pp. 173-181(9)
Authors: Mellemkjær L.; Blot W.J.; Sørensen H.T.; Thomassen L.; McLaughlin J.K.; Nielsen G.L.; Olsen J.H.

Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease
pp. 183-188(6)
Authors: Visser L.E.; Graatsma H.H.; Stricker B.H.C.

Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo
pp. 189-192(4)
Authors: Wilkinson I.B.; MacCallum H.; Cockcroft J.R.; Webb D.J.

Local nitric oxide release does not affect tachyphylaxis to angiotensin II in dorsal hand veins in man in the presence of prostaglandin synthesis inhibition
pp. 193-195(3)
Authors: de Haas S.L.; Wilkinson I.B.; Boyd J.L.; Webb D.J.

Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon
pp. 196-202(7)
Authors: Stone B.M.; Turner C.; Mills S.L.; Paty I.; Patat A.; Darwish M.; Danjou P.

The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects
pp. 203-206(4)
Authors: Saima S.; Furuie K.; Yoshimoto H.; Fukuda J.; Hayashi T.; Echizen H.

Frequency of adverse drug reactions in children: A prospective study
pp. 207-210(4)
Authors: Jonville-Béra A.P.; Giraudeau B.; Blanc P.; Beau-Salinas F.; Autret-Leca E.

Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE Study
pp. 211-212(2)

Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz
pp. 212-214(3)

Recreational bupropion abuse in a teenager
pp. 214-214(1)

Review for Graduate Therapeutics: A Primer for MRCP and Specialist Training
pp. 215-215(1)

Muscarinic receptors in airways diseases
pp. 215-216(2)

Modern immunosuppressives
pp. 216-217(2)

Corrigendum
pp. 218-218(1)